BUY Havells India Ltd. — Manas Jaiswal
Havells India share price target & all analyst calls
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via CNBC Awaaz.
Entry₹1,305Inferred
Stop loss₹1,279-1.99% risk
Exit₹1,27919 Aug 2026, 10:55 am
Stop-loss hit-1.99%
Follow Manas Jaiswal for new calls(30% target hit, 380 closed calls)Get alertsWatch HAVELLS for new buy/sell callsGet alertsSee 2 active Swing calls on HAVELLSSee 149 active Swing picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting1 opposing
Supports the BUY call (1)
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·29 Jul · 3w ago
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (1)
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Havells India
- BUY — ICICI Securities23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY — Goldman Sachs23 Oct 2026 · ~1 year · target ₹1,225 · Active
- BUY — HSBC Securities23 Oct 2026 · ~1 year · target ₹1,400 · Active
- SELL — Shrikant Chouhan, Kotak Securities22 Oct 2026 · ~2 weeks · target ₹1,000 · Active
- BUY — Ruchit Jain, Motilal Oswal14 Oct 2026 · ~2 weeks · target ₹1,140 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active